BIOVENTUS INC. Net Income (Loss) Available to Common Stockholders, Diluted
BIOVENTUS INC. (BVS) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$158.70 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-03-31
- BIOVENTUS INC. net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was -$31.93M.
- BIOVENTUS INC. net income (loss) available to common stockholders, diluted for the quarter ending 2022-10-01 was -$108.25M.
- BIOVENTUS INC. net income (loss) available to common stockholders, diluted for the quarter ending 2022-07-02 was -$7.25M.
- BIOVENTUS INC. net income (loss) available to common stockholders, diluted for the quarter ending 2022-04-02 was -$11.28M.
- BIOVENTUS INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$158.70M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 5 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 7 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 10 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$31.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$140.18M derived: sum of 2 quarters · filed 2023-03-31 | -$147.43M derived: sum of 3 quarters · filed 2023-03-31 | -$158.70M 10-K · filed 2023-03-31 | |||
| 2022-10-01 | -$108.25M 10-Q · filed 2022-11-21 | -$115.50M derived: sum of 2 quarters · filed 2022-11-21 | -$126.77M 10-Q · filed 2022-11-21 | ||||
| 2022-07-02 | -$7.25M 10-Q · filed 2022-08-12 | -$18.53M 10-Q · filed 2022-08-12 | |||||
| 2022-04-02 | -$11.28M derived: 10-K 12 month − 3 quarters · filed 2023-03-31 | ||||||
| 2021-12-31 | -$6.60M 10-K · filed 2023-03-31 | ||||||
| 2021-10-02 | -$1.07M 10-Q · filed 2022-11-21 | -$5.20M derived: sum of 2 quarters · filed 2022-11-21 | -$6.24M 10-Q · filed 2022-11-21 | ||||
| 2021-07-03 | -$4.13M 10-Q · filed 2022-08-12 | -$5.17M 10-Q · filed 2022-08-12 |